Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pharmacogenetics or "farm-ecogenetics"?].

Journal de la Societe de biologie - 1 Jan 2000

Gérard N, Elion J, Krishnamoorthy R

Abstract excerpt

Pharmacogenetics and ecogenetics constitute the study of the contribution of genetic factors in interindividual variations in drugs and xenobiotics metabolism respectively and also its physiopathology (toxicity, therapeutic failure and pejorative effect). However, the frontiers between these two fields are interpenetrant with no defined limits. Among the enzymes involved in transformation of drugs/xenobiotics,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation
Share to Drug Hypersensitivity
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Forecasting

Share to Inactivation, Metabolic

Share to Microsomes, Liver

Share to Pharmacokinetics

Share to Xenobiotics

Source

Identifiers

PMID: 11107543
DOI: 10.1051/jbio/2000194010009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pharmacogenetics or "farm-ecogenetics"?].PMID 11107543Read ↗

[Pharmacogenetics: pharmacokinetics and clinical implications].Semantic proximity Read ↗

[Contribution of genotyping and phenotyping of biotransformation in therapeutic drug monitoring].Semantic proximity Read ↗

Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.Semantic proximity Read ↗

Pharmacogenetics of cytochrome P450 (CYP) in the elderly.Semantic proximity Read ↗

Pharmacogenetics, pharmacogenomics and ecogenetics.Semantic proximity Read ↗

Pharmacogenetics and ecogenetics in 1991.Semantic proximity Read ↗

Genetics/genomics and drug effects.Semantic proximity Read ↗

[Clinical significance of some genetic polymorphisms of cytochrome P-450: family CYP1 and subfamilies CYP2A, CYP2B and CYP2C].Semantic proximity Read ↗

[Clinical significance of some genetic polymorphisms of cytochrome P-450 subfamilies CYP2D, CYP2E and CYP3A--part II].Semantic proximity Read ↗

[Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure].Semantic proximity Read ↗

[Pharmacogenomics: way to individual therapy].Semantic proximity Read ↗

[Drug therapy and pharmacogenomics--hopes and facts].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.